Your browser doesn't support javascript.
loading
The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mammalian proteomes.
Davydova, Erna; Shimazu, Tadahiro; Schuhmacher, Maren Kirstin; Jakobsson, Magnus E; Willemen, Hanneke L D M; Liu, Tongri; Moen, Anders; Ho, Angela Y Y; Malecki, Jedrzej; Schroer, Lisa; Pinto, Rita; Suzuki, Takehiro; Grønsberg, Ida A; Sohtome, Yoshihiro; Akakabe, Mai; Weirich, Sara; Kikuchi, Masaki; Olsen, Jesper V; Dohmae, Naoshi; Umehara, Takashi; Sodeoka, Mikiko; Siino, Valentina; McDonough, Michael A; Eijkelkamp, Niels; Schofield, Christopher J; Jeltsch, Albert; Shinkai, Yoichi; Falnes, Pål Ø.
Afiliação
  • Davydova E; Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway.
  • Shimazu T; Cellular Memory Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan.
  • Schuhmacher MK; Department of Biochemistry, Institute of Biochemistry and Technical Biochemistry, University of Stuttgart, Allmandring 31, 70569, Stuttgart, Germany.
  • Jakobsson ME; Proteomics Program, Faculty of Health and Medical Sciences, Novo Nordisk Foundation Center for Protein Research (NNF-CPR), University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.
  • Willemen HLDM; Department of Immunotechnology, Lund University, Medicon Village, 22100, Lund, Sweden.
  • Liu T; Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht University, 3584, Utrecht, EA, The Netherlands.
  • Moen A; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK.
  • Ho AYY; Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway.
  • Malecki J; Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway.
  • Schroer L; Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway.
  • Pinto R; Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway.
  • Suzuki T; Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway.
  • Grønsberg IA; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Sohtome Y; Biomolecular Characterization Unit, Technology Platform Division, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.
  • Akakabe M; Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway.
  • Weirich S; Synthetic Organic Chemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan.
  • Kikuchi M; RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.
  • Olsen JV; Synthetic Organic Chemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan.
  • Dohmae N; Department of Biochemistry, Institute of Biochemistry and Technical Biochemistry, University of Stuttgart, Allmandring 31, 70569, Stuttgart, Germany.
  • Umehara T; Laboratory for Epigenetics Drug Discovery, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.
  • Sodeoka M; Proteomics Program, Faculty of Health and Medical Sciences, Novo Nordisk Foundation Center for Protein Research (NNF-CPR), University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.
  • Siino V; Biomolecular Characterization Unit, Technology Platform Division, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.
  • McDonough MA; Laboratory for Epigenetics Drug Discovery, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.
  • Eijkelkamp N; Synthetic Organic Chemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan.
  • Schofield CJ; RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.
  • Jeltsch A; Department of Immunotechnology, Lund University, Medicon Village, 22100, Lund, Sweden.
  • Shinkai Y; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK.
  • Falnes PØ; Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht University, 3584, Utrecht, EA, The Netherlands.
Nat Commun ; 12(1): 891, 2021 02 09.
Article em En | MEDLINE | ID: mdl-33563959
Post-translational methylation plays a crucial role in regulating and optimizing protein function. Protein histidine methylation, occurring as the two isomers 1- and 3-methylhistidine (1MH and 3MH), was first reported five decades ago, but remains largely unexplored. Here we report that METTL9 is a broad-specificity methyltransferase that mediates the formation of the majority of 1MH present in mouse and human proteomes. METTL9-catalyzed methylation requires a His-x-His (HxH) motif, where "x" is preferably a small amino acid, allowing METTL9 to methylate a number of HxH-containing proteins, including the immunomodulatory protein S100A9 and the NDUFB3 subunit of mitochondrial respiratory Complex I. Notably, METTL9-mediated methylation enhances respiration via Complex I, and the presence of 1MH in an HxH-containing peptide reduced its zinc binding affinity. Our results establish METTL9-mediated 1MH as a pervasive protein modification, thus setting the stage for further functional studies on protein histidine methylation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteoma / Metilistidinas / Metiltransferases Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteoma / Metilistidinas / Metiltransferases Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article